| # | Drug | Count |
|---|---|---|
| 0 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 |
| 1 | ADALIMUMAB | 1 |
| 2 | ATORVASTATIN CALCIUM | 1 |
| 3 | AZACITIDINE | 1 |
| 4 | AZACITIDINE FOR | 1 |
| 5 | ESOMEPRAZOLE MAGNESIUM | 1 |
| 6 | ITRACONAZOLE | 1 |
| 7 | METOPROLOL | 1 |
| 8 | METOPROLOL TARTRATE | 1 |
| 9 | METOROPROLOL TARTRATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 1 | ITRACONAZOLE | 1 | 0.0001 |
| 2 | AZACITIDINE | 1 | 0.0000 |
| 3 | VENETOCLAX | 1 | 0.0000 |
| 4 | ROSUVASTATIN | 1 | 0.0000 |
| 5 | ESOMEPRAZOLE MAGNESIUM | 1 | 0.0000 |
| 6 | ATORVASTATIN CALCIUM | 1 | 0.0000 |
| 7 | PREGABALIN | 1 | 0.0000 |
| 8 | METOPROLOL TARTRATE | 1 | 0.0000 |
| 9 | ADALIMUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 |
| 1 | Azole Antifungal [EPC] | 1 |
| 2 | BCL-2 Inhibitor [EPC] | 1 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |